|
Tuesday, March 4 — 8:00 AM — CC Korbel BR 1
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section B - BREAST PATHOLOGY
Chaired by: Timothy Jacobs and Margaret Steinhoff
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Differences in Prognostic Marker Expression in Female Breast Carcinoma with Brain Versus Bone Metastases
(213)
SR Patel, VB Reddy, KP Siziopikou, P Gattuso - Rush University Medical Center, Chicago, IL
|  Add |
| 8:15 |
Clinical, Morphologic and Immunophenotypic Characteristics of Breast Carcinomas with Lung Metastasis
(214)
A Patil, T Nehhozina, M Akram, S Patil, E Brogi - Memorial Sloan-Kettering Cancer Center, New York
| Add |
| 8:30 |
Human Breast Carcinosarcomas Exhibit a Biphasic Her-2/neu Expression Pattern Due to Alterations in Receptor Heterodimerization and Downstream Signaling
(89)
SH Barsky, J Ostler, L Gentchev, RE Jimenez - The Ohio State University College of Medicine, Columbus, OH
| Add |
| 8:45 |
Application of the ASCO/CAP Guidelines for HER2 Testing to mRNA Expression Values from Microarrays
(239)
AN Shaye, Y Gong, K Yan, N Sneige, FJ Esteva, GN Hortobagyi, L Pusztai, WF Symmans - University of Texas MD Anderson Cancer Center, Houston, TX; University of Texas MD Anderson Cancer Center, Houston, TX
| Add |
| 9:00 |
Choice of Primary Anti-HER2 Antibody Affects Concordance of Immunohistochemistry with Fluorescence In Situ Hybridization for Determination of Breast Cancer HER2 Status
(141)
AM Gown, LC Goldstein, TS Barry, PL Kandalaft, SJ Kussick, CC Tse - PhenoPath Laboratories, Seattle, WA
| Add |
| 9:15 |
Correlation of Chromosome 17 Polysomy with Her2/neu Immunohistochemistry Status
(178)
U Krishnamurti, J Lindner, F Atem, P Storto, J Silverman - West Penn Hospital, Allegheny General Hospital and University of Pittsburgh, Pittsburgh, PA
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
| |
| 11:00 |
Fixation Issues with Breast Carcinoma Hormone Receptors: ER Negative PR Positive Carcinomas Exist Even with Optimal Fixation Methods
(111)
DJ Dabbs, GJ Carter, R Bhargava - Magee-Womens Hospital of UPMC, Pittsburgh, PA
| Add |
| 11:15 |
Successful Design of Low-Level Estrogen Receptor Positive Tissue Controls for Critical Quality Control Measures
(143)
R Grimes, E Saiz, B Sanchez, H Yaziji - Mt. Sinai Medical Center, Miami Beach, FL; Vitro Molecular Laboratories, Miami, FL
| Add |
| 11:30 |
The Extent of Retraction Artifact Correlates with Lymphatic Vessel Density and VEGF-C Expression in Early Stage Breast Carcinoma and Predicts the Presence of Nodal Metastasis
(212)
G Paragh, X Xu, T Pasha, PJ Zhang, G Acs - H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Pennsylvania Medical Center, Philadelphia, PA
| Add |
| 11:45 |
A Multinstitutional Study Comparing the Oncotype-DX Recurrence Rates with Standard Clinical and Pathological Features of Breast Cancer, the Nottingham Prognostic Index and ADJUVANT! Online
(152)
O Hameed, G Acs, SM Al-Khatib, EM Hattab, JS Lewis, H Nassar, E Rajan, P Rajan, DC Sgroi, B Sharafaldeen, O Tawfik - University of Alabama School of Medicine, Birmingham, AL; H. Lee Moffitt Cancer Center; Indiana University; Washington University School of Medicine; Wayne State University; Loyola University Chicago Medical Center; Massachusetts General Hospital; Kansas University Medical Center
| Add |
|
|
